Results per Page:
Surprising findings about blood cell mutations bode well for transplant recipients
Fred Hutch researchers compared blood samples from 16 recipient-donor pairs, some more than 45 years after transplant
Microbial cell-free DNA may help predict transplantation outcomes
From the Markey Lab, Translational Science and Therapeutics Division
Depleting exhausted T cells enables memory T cells to be activated and fight blood cancer
From the Hill Lab, Clinical Research Division
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
Novel transplant approach improves the odds for leukemia patients
Naïve T cells that lead to graft-vs.-host disease removed with magnets
A lasting impression: CMV exposure imprints donor T cell phenotypes
From the Hill Lab, Clinical Research Division
Tip Sheet: New COVID-19 transmission study, returning to school, video of biorepositories — and a new weight loss study
Summaries of recent Fred Hutch research findings and other news
Landmark scientific paper turns 40
First unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy, modern bone marrow transplantation
A new option for high-risk multiple myeloma?
Study of three-step treatment approach reopens question of donor bone marrow transplant
Age no longer should be a barrier to stem cell transplantation for older patients with blood cancers
Study details outcomes of patients who received the ‘mini transplant’ developed at Fred Hutchinson Cancer Research Center
Multiple Myeloma: Turning a Once-Deadly Disease into a Manageable Disease
June 15 forum will detail latest treatments to combat this cancer of the elderly